Ketamine as an alternative to ECT in catatonia in elderly women with bipolar disorder: A case report

Shanthi Sarma, Arulmathy Arunachalam, Memunatu Kamara, Grace Branjerdporn*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

54 Downloads (Pure)

Abstract

The following paper described two cases of patients with catatonic depression in bipolar disorder (BD) referred to our electroconvulsive therapy (ECT) service. Both were deemed not medically fit for ECT, and were, instead, treated with intravenous (IV) ketamine. Both responded with a resolution of symptoms, returning to baseline level of functioning. During the COVID-19 pandemic, given the risks associated with providing ECT (an aerosol generating procedure) and, in the context of limited resources, ketamine therapy for catatonia is a potentially beneficial alternative or supportive treatment to ECT that merits additional research.

Original languageEnglish
Article number1138772
Pages (from-to)1-4
Number of pages4
JournalFrontiers in Psychiatry
Volume14
DOIs
Publication statusPublished - 13 Apr 2023
Externally publishedYes

Fingerprint

Dive into the research topics of 'Ketamine as an alternative to ECT in catatonia in elderly women with bipolar disorder: A case report'. Together they form a unique fingerprint.

Cite this